C225045Level 6
Ibrutinib/Pembrolizumab Regimen
**Semantic type:** Therapeutic or Preventive Procedure
**Definition:** A regimen consisting of ibrutinib and pembrolizumab that can be used for the treatment of chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL).
**Synonyms:** - Ibrutinib-Pembrolizumab - Ibrutinib/Pembrolizumab - Imbruvica/Keytruda - Keytruda/Imbruvica - Pembrolizumab-Ibrutinib - Pembrolizumab/Ibrutinib
GET
/api/v1/systems/nci_thesaurus/nodes/C225045Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.